Teva Recalls Fluoxetine Capsules Due to Chemical Contamination and Odor
Teva Pharmaceuticals is recalling Fluoxetine Capsules due to a customer complaint trend regarding capsule odor, indicating chemical contamination.
What this means for you
Minor labeling or packaging issue, or a voluntary precautionary recall. Risk of harm is low but real — follow the manufacturer's instructions.
Our severity reasoning: The recall is classified as FDA Class II, which typically involves a situation where use of, or exposure to, a violative product may cause temporary or medically reversible adverse health consequences. The hazard is identified as chemical contamination based on odor complaints, without reported serious injuries or fatalities.
Plain-English summary
Teva Pharmaceuticals USA is recalling Fluoxetine Capsules USP, 20 mg, in 100, 500, 1000, and 2000-count bottles. The recall is due to a customer complaint trend regarding capsule odor, which indicates chemical contamination.
The affected product is manufactured in Poland by Pliva Krakow Pharmaceutical Company S.A. and distributed nationwide and in Puerto Rico. The recall covers 257,904 bottles across multiple lot numbers with expiration dates ranging from September 2015 to December 2015.
Consumers should stop using the recalled product and contact their healthcare provider or pharmacist for guidance on obtaining a replacement. The specific lot numbers and expiration dates are listed in the official recall notice.
The recalled product
- Product
- FLUOXETINE (FLUOXETINE)
- Brand
- FLUOXETINE
- Manufacturer
- Teva Pharmaceuticals USA
- Category
- Drug — Prescription Medication
- Affected units
- 257,904
Is your product affected?
Check your packaging against the codes below. If any of them match, the product is part of this recall.
Lot numbers (20)
- Lot #: a) 6A211150
- 6A211151
- 6A211152
- 6A211153
- 6A211154
- Exp 11/15
- 6A212083
- 6A212084
- 6A212085
- 6A212086
- Exp 12/15
- b) 6A211143
- 6A211145
- 6A211146
- 6A211147
- c) 6A209116
- 6A209117
- 6A209118
- 6A209119
- 6A209120
Distribution
Part of a larger recall action
This product is one of 2 recalled by Teva Pharmaceuticals USA under a single FDA (Drugs) recall action. The agency files each product separately, so the size of the action is not visible from this page alone.
See all 2 products in this recall →Related recalls
Same brand · FLUOXETINE
- HighFluoxetine Tablets USP 20 mg Recalled for N-Nitroso Contamination
FDA (Drugs) · 2025-06-11
- SevereFluoxetine Tablets 20 mg Recalled for N-Nitroso Impurity
FDA (Drugs) · 2025-06-11
- ModerateTeva Recalls Fluoxetine Capsules Due to Residual Solvent Impurity
FDA (Drugs) · 2015-05-06
- SevereTeva Recalls Fluoxetine Capsules Due to Residual Solvent Impurity
FDA (Drugs) · 2015-05-06
- ModerateLegacy Pharmaceutical Packaging Recalls Fluoxetine Capsules Due to Odor Complaints
FDA (Drugs) · 2014-05-07
Same manufacturer · Teva Pharmaceuticals USA
See all →- ModerateDoxylamine Succinate and Pyridoxine Hydrochloride Tablets Recalled for Failed Dissolution
FDA (Drugs) · 2022-02-09
- LowPrescription Drug Recall: Mimvey Mislabeling by Teva Pharmaceuticals
FDA (Drugs) · 2022-02-09
- ModerateTretinoin Capsules 10 mg Recalled for Failed Dissolution Specifications
FDA (Drugs) · 2022-02-09
- LowMimvey Estradiol/Norethindrone Prescription Drug Mislabeling Recall
FDA (Drugs) · 2022-02-09
- ModerateBrinzolamide Ophthalmic Suspension recalled for defective container caps
FDA (Drugs) · 2022-01-26
Same hazard · chemical contamination
See all →- SevereAmerican Regent Recalls Acetylcysteine Solution Due to Particulate Matter
FDA (Drugs) · 2026-08-26
- SevereGas-X Extra Strength softgels contaminated with propylene glycol machine coolant
FDA (Drugs) · 2026-06-17
- HighDragonfly Thai ginger powder may be contaminated with lead
FDA (Food) · 2026-06-17
- SevereNaproxen Oral Suspension Recalled for Lead and Lithium Contamination
FDA (Drugs) · 2026-05-13
- HighFarmHouse Fresh benzoyl peroxide night lotion recalled over benzene contamination
FDA (Drugs) · 2026-04-22